dosavadní publikační činnost, která je ve vztahu k problematice
1. ID 549128 An Assessment of Novel Biomarkers in Bone Metastatic Disease Using Multiplex Measurement and Multivariate Analysis. Windrichova J, Kucera R, Fuchsova R et al., Technology in Cancer Research & Treatment (2018) 17, Cite score 2018 2,3 (according to Scopus)
2. ID 143736 The role of MonoTotal in the primary diagnosis, prognosis and follow-up of patients with non-small cell lung cancer (NSCLC). Prazakova M, Vrzalova J, Auge JM, et al., Anticancer Res. 2011;31(9):3107-3112., IF 1,725
3. ID 497952 PHI in the early detection of prostate cancer. Fuchsova R,Topolcan O,Windrichova J,et al., Anticancer Research (2015) 35(9) 4855-4858, IF 1,895
4. ID 352938 Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease. Safranek J, Pesta M, Holubec L, et al. Anticancer Res. 2009;29(7):2513-2517, IF 1,428
5. ID 534200 Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC. Fiala O, Hosek P, Pesek M, et al., Anticancer Res. 2017;37(11):6469-6476. doi:10.21873/anticanres.12102, IF 1,865
6. ID 528457 The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab. Fiala O, Pitule P, Hosek P, et al., Tumour Biol. 2017;39 (7):1010428317709283. doi:10.1177/1010428317709283, IF 3,650